dibenzylchlorethamine has been researched along with Amyloidosis in 1 studies
Dibenzylchlorethamine: An alpha adrenergic antagonist.
Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebbesen, P | 1 |
1 other study available for dibenzylchlorethamine and Amyloidosis
| Article | Year |
|---|---|
On the influence of exogeneous cyclic AMP (3',5'-adenosine monophosphate) on amyloid formation in casein-treated C3H mice.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Albuterol; Amyloid; Amyloidosis; Animals; Bucla | 1974 |